Holiday Center Times - Awards for Oct. 2016

Federal Awards

Burgess, Shawn, Duke Univ/NIH, Development of Novel Therapies for NIDDM, Project 3, $87,451; Cleaver, Ondine, Univ of Missouri/NIH, Novel Growth Factor and Signaling Requirements for Human Capillary Tube Assembly, $82,254; Desai, Dev, Stanford Univ/NIH, Biomarkers for Post-Transplant Lymphoproliferative Disorders in Children, $37,658; Kittler, Ralf, UTMB Galveston/NASA, Molecular Characterization of Transmissible Chromosome Aberrations, $7,520; Koh, Andrew, NIH, Candida Albicans Gastrointestinal Colonization and Dissemination, $405,000; Koh, Andrew, Giner Inc/CDC, Highly Sensitive Electrochemical Assay to Monitor Gut Microbiome, $40,000;

Kraus, William, NIH, Activity of Nuclear Receptor Coregulators with Chromatin, $449,926; Lea, Jayantha, Texas Tech/Dept of Defense, Novel Platinum/Taxane-Based Drug Combinations (Preclinical) for Ovarian Cancer, $10,767; Lee, William, Univ of Michigan/NIH, Michigan Hepatotoxicity Clinical Research Network, $3,000; Lega, Bradley, Columbia Univ/NIH, The Role of Place and Grid Cells in Human Spatial Navigation and Memory, $50,065; McKnight, Steven, NIH, Reversible Polymerization of Low Complexity Polypeptide Sequences as a Framework for Transcriptional Control in Eukaryotic Cells, $490,933; Munshi, Nikhil, NIH, Defining Process Control Parameters for Cardiac Reprogramming, $81,000;

Nwariaku, Ohwofiemu, NIH, Partnerships to Develop Injury Research Capacity in the Sub-Saharan Africa, $221,067; Otwinowski, Zbyszek, Washington Univ at St. Louis/NIH, Structural Mechanisms of Ebola Virus RNA Synthesis – Core A, $56,672; Otwinowski, Zbyszek, Northwestern Univ/NIH, Center for Genomic Structures of Infectious Diseases, $42,661; Pan, Duojia, NIH, Control of Cell Number in Developing Retina, $405,000; Rahn, David, NIH, Pelvic Floor Disorders Network 2015, $72,864; Raskin, Philip, Univ of South Florida/NIH, TrialNet Affiliate Services, $265,481;

Roberts, Todd, NIH, All-Optical Methods for Studying Sequential Motor Behaviors, $112,400; Rubin, Craig, UT HSC San Antonio/NIH, UT MSTAR in Aging Research, $15,296; Sakhaee, Khashayar, Natl Marine Mammal Fdn/Office of Naval Research, Metabolic Studies to Formulate Prevention and Treatment Strategies for Ammonium Urate Nephrolithiasis in Navy Dolphins, $120,361; Sherry, Dean, Duke Univ Med Ctr/NIH, Development of Novel Therapies for NIDDM, Core A, $39,750; Siegwart, Daniel, US Dept of Defense, Defining Hepatocellular Carcinoma Subtypes and Treatment Responses in Patient-Derived Tumorgrafts, $149,672;

Stull, James, UT HSC Houston/NIH, Mutations in Smooth Muscle Contractile Proteins: Pathways to Vascular Diseases, $402,580; Ufret-Vincenty, Rafael, NIH, Role of Complement Factor H and Immunity in AMD: a Novel Transgenic Model, $397,500; Wetzel, Dawn, Dartmouth College/NIH, The Role of Flagellar Motility to Innate Immune Recognition of Bacteria, $15,857; Williamson, Jon, Dallas Fdn/The Belo Fdn/DHHS, Project NTARUPT - Dallas Teenage Pregnancy Prevention Program, $161,554; Yopp, Adam, US Dept of Defense, Defining Hepatocellular Carcinoma Subtypes and Treatment Responses in Patient-Derived Tumorgrafts, $141,637.

Non-Federal Awards

Alto, Neal, Howard Hughes Med Inst, The Molecular Architecture of Host-Pathogen Interactions, $120,000; Chen, Elizabeth, Howard Hughes Med Inst, HHMI Faculty Scholar 2016, $180,000; Cobb, Melanie (Fellow H. Dbouk), Amer Heart Assoc SW, Characterization of WNK1-PI3-Kinase Interaction and its Role in Endothelial Cell, $49,340; Danuser, Gaudenz, CPRIT, Computational Live Cell Histology, $127,272; Danuser, Gaudenz, Univ of NC at Chapel Hill, Spatio-Temporal Dynamics of GET- GT Pase Networks, $76,526; Deberardinis, Ralph, Howard Hughes Med Inst, HHMI Faculty Scholar 2016, $120,000; Douglas, Peter, Glenn Fdn for Med Research, The Glenn Award for Research in Biological Mechanisms of Aging, $30,000; Dowling, Michael, Univ of Calif at San Francisco/PED Epilepsy Res Fdn, Seizures in Pediatric Stroke II (SIPS II), $4,575;

Greene, Robert, Sleep Research Society Fdn, SRS 2016 Support Award, $25,000; Hill, Joseph (Fellow S. Kim), Amer Heart Assoc SW, BET Bromodomain Protein-Dependent Regulation of Cardiac Hypertrophy, $25,950; Lin, Ken, Washington Univ/Amer Board of OBGYN, Reproductive Scientist Development Program (ABOG), $6,250; Lin, Milo, Heising-Simons Fdn, Leveraging Symmetry to Predict Protein Self-Assembly, $70,380; Mangelsdorf, David, Welch Fdn, Ligand Binding Properties of Nematode Orphan Nuclear Receptors, $110,000; Morrison, Sean (Fellow K. Ahlqvist), Human Frontier Science Pgm, Deciphering the Mitochondrial Fingerprint of Hematopoietic Stem Cell Aging, $61,080; Mukhopadhyay, Saikat, CPRIT, Recruitment of First-time Tenure-Track Faculty, $504,350; Olson, Daiwai, Sigma Theta Tau Intl, Manuscript Bootcamp for Nursing Fellows, $9,624; Pan, Duojia (Fellow J. Phillips), Life Sciences Research Fdn, Utilizing Unicellular Organisms to Characterize Hippo Pathway Regulation, $60,000;

Pfeiffer, Julie, Howard Hughes Med Inst, Enteric Virus-Microbiota Interactions, $240,000; Raman, Lakshmi (Fellow P. Pandiyan), Extracorporeal Life Support Org, Prospective Analysis of Neuroinflammation, Neuronal Injury (ECMO), $5,000; Ranganathan, Rama, Welch Fdn, Evolutionary Dynamics and the Design of Natural Proteins, $110,000; Ross, Theodora, CPRIT, Detecting Unaffected Individuals for Lynch Syndrome (DUAL): Screening, Diagnosis, $705,005; Ross, Theodora, CPRIT, Use of Genetic Patient Navigators to Help Mutation Carriers Comply with the NCCN, $132,462; Sperandio, Vanessa, Burroughs Wellcome Fund, Burroughs Wellcome Seminar Award for Eric Skaar, $1,000; Thomas, Philip, Cystic Fibrosis Fdn, Development of Methods and Reagents for Assessing CFTR, $318,922; Tsai, Peter, Child Neurology Fdn, Cerebellar-Cortical Circuit in ASD, $50,000; Tu, Benjamin, Howard Hughes Med Inst, HHMI Faculty Scholar 2016, $120,000; Xie, Yang, CPRIT, Core C2: Biostatistics, Bioinformatics and Database Core, $149,988.

Industry Sponsored Awards

(Dollar amounts not available)

Adhikari,Soumya, Sanofi US, Study of Insulin Glargine and Lantus in 6-17 Yr Children with Type 1 Diabetes Mellitus; Agostini, Mark, Neuropace, RNS System Post-Approval Study in Epilepsy; Beg, Muhammad Shaalan, Merck Sharp & Dohme, Phase 3 Study of Pembrolizumab vs. Chemotherapy for Stage IV Colorectal Carcinoma; Chen,Ping-Chi Benjamin, Peloton Therapeutics, Radiosensitization by PT2385 in the HN5 Model; Courtney, Kevin Dale, Astellas Pharma US, Phase 3 Study of Enzalutamide Plus Androgen Deprivation Therapy for Metastatic Hormone Sensitive Prostate Cancer; Frankel, Arthur, Eli Lilly & Company, Phase 1B/2 Study of Gemcitabine and Docetaxel for Advanced Soft Tissue Sarcoma; Frankel, Arthur, IGNYTA, Phase 2 Study of Entrectinib for Solid Tumors that Harbor NTRK1/2/3, ROS1, or ALK Gene Rearrangements; Gao,Jinming, Onconano Medicine, Evaluate OncoNano Clinical Candidate Probes for Performance and Safety;

Huang, Chou-Long, Boehringer Ingelheim Pharma, Ability of TRPC6 Small Molecule Antagonist to Inhibit Cardiac Hypertrophy in Preclinical Models of Cardiac Dysfunction; Jain, Raksha, Univ of Calif, San Diego/Gilead Sciences, Multicenter Clinical Phenotyping of Cystic Fibrosis; Lotan,Yair, FKD Therapies Oy, Phase 3 Study of Instiladrin for High Grade, BCG Unresponsive Non-Muscle Invasive Bladder Cancer; Mayo,Marlyn Jean, NGM Biopharma Australia, Phase 2 Study of NGM282 for Primary Sclerosing Cholangitis; Rogers, Zora R, Pfizer, Study of Rivipansel for Vaso-Occlusive Crises in Sickle Cell Disease; Sumpter, Kathryn Maria, Novo Nordisk, Faster-Acting Insulin Aspart for Children and Adolescents with Type 1 Diabetes; Tamminga, Carol, Pfizer, Investigation of M4 Positive Allosteric Modulator in Brain cFos Transcription.